Repurposing FDA-approved drugs as multi-stage antimalarials: An in silico investigation

Key Points

• Findings reveal several FDA-approved drugs with potential as multi-stage antimalarials, enhancing treatment options.
• The investigation utilized in silico techniques, including molecular docking, for drug repurposing analysis.
• Assessment involved targeting multiple stages of the malaria parasite lifecycle, crucial for effective treatment.
• These results highlight the promise of existing medications in tackling malaria, but clinical trials are necessary.